The Emerging Role of Personalized Medicine in Immunotherapy for Ovarian Cancer
Publish place: Personalized Medicine Journal، Vol: 7، Issue: 27
Publish Year: 1401
Type: Journal paper
Language: English
View: 190
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- I'm the author of the paper
Export:
Document National Code:
JR_PMJ-7-27_004
Index date: 14 January 2023
The Emerging Role of Personalized Medicine in Immunotherapy for Ovarian Cancer abstract
The ability of immunotherapy to treat ovarian cancer is currently limited, however evaluating sensitive/resistant target treatment subpopulations based on stratification by tumor biomarkers may enhance this ability. These indicators include the number of tumor mutations, PD-L1, tumor-infiltrating lymphocytes, a lack of homologous recombination, and intratumoral heterogeneity of neoantigens. The use of these indicators to choose the best candidates for ovarian cancer treatment is one of the future directions. In addition to reviewing innovative treatments and study designs including tumor biomarkers that improve the chances of immunotherapy success in ovarian cancer, this paper also analyzes the function of immunotherapy in ovarian cancer.
The Emerging Role of Personalized Medicine in Immunotherapy for Ovarian Cancer Keywords:
The Emerging Role of Personalized Medicine in Immunotherapy for Ovarian Cancer authors
Muhmmad Noor Kazkaz
Jarallh German specialized clinic laboratory,Kuwait, Kuwait Kuwait German Urology Unit(KGUU)